Did you think it was over? Just for a moment, maybe – as the vaccination numbers rose, or the mercury; when the lockdowns lifted; as the masks dropped? The validation of Covid-19 vaccines will go down in history as a turning point during this pandemic, but with

AEGIS LIFE, INC. CONTINUES JOURNEY TO END PANDEMIC WITH COVID-19 DNA VACCINES Published by: Aegis Life Watch recording of Propel(x) Presents: Path to a COVID-19 Vaccine The COVID-19 vaccine developed by Pfizer and BioNTech SE prevented more than 90% of infections in a late-stage study, according to preliminary results. Vaccine development

AEGIS LIFE, INC. APPOINTS HONG JIANG, PH.D. AS CHIEF OPERATING OFFICER Published by: Aegis Life SAN DIEGO – September 9, 2020 – Aegis Life, Inc., the leading developer of the next generation of DNA vaccines and therapies for the world’s most dangerous diseases, announced today that it has

AEGIS LIFE, INC. LAUNCHES TO FIGHT COVID-19 VIA DNA VACCINES AND THERAPEUTICS ENABLED BY PROPRIETARY FUSOGENIX DELIVERY TECHNOLOGY Published by: Aegis Life Phase 1 Clinical Trial of Aegis Life’s First SARS-CoV-2 DNA Vaccine Planned for Fall 2020 Company Spun Out of Entos Pharmaceuticals SAN DIEGO – September